NA
FLGT icon

NewEdge Advisors’s Fulgent Genetics FLGT Stock Holding History

NewEdge Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-225
Closed -$5.91K – 4235
2025
Q4 		$5.91K Hold
225
– – ﹤0.01% 3632
2025
Q3 		$5.08K Hold
225
– – ﹤0.01% 3531
2025
Q2 		$4.47K Hold
225
– – ﹤0.01% 3437
2025
Q1 		$3.8K Buy
+225
New +$3.83K ﹤0.01% 3371
2023
Q2 		– Sell
-235
Closed -$7.34K – 3531
2023
Q1 		$7.34K Sell
235
-318
-58% -$10.2K ﹤0.01% 2667
2022
Q4 		$9.48K Buy
+553
New +$19.8K ﹤0.01% 2389
2021
Q2 		– Sell
-3,095
Closed -$299K – 1160
2021
Q1 		$299K Buy
+3,095
New +$319K 0.01% 816

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

NewEdge Advisors's FLGT Position: Q1 2026 in Review

NewEdge Advisors sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 225 shares — an estimated $5.91K sold.

NewEdge Advisors first reported a position in FLGT in Q1 2021 and held it in 7 quarters. The position peaked at $299K in Q1 2021. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • NewEdge Advisors reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • NewEdge Advisors sold 225 Fulgent Genetics shares in Q1 2026, an estimated $5.91K.
  • NewEdge Advisors first reported a position in Fulgent Genetics in Q1 2021 and held it in 7 quarters.
  • NewEdge Advisors's Fulgent Genetics position peaked at $299K in Q1 2021.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.